SCHEMBL21865610

SCHEMBL21865610

O=c1cc(-c2ccc(OBr)cc2)oc2c(Cl)cccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR1 Q9Y271 1/20 0.53
CYP1A1 P04798 9/20 0.52
CYP1B1 Q16678 9/20 0.52
CYP1A2 P05177 8/20 0.52
ABCB1 P08183 2/20 0.52
ABCC1 P33527 2/20 0.52
ABCG2 Q9UNQ0 2/20 0.52
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 3/20 0.48
TP53 P04637 3/20 0.48
CYP3A4 P08684 3/20 0.48
MAPT P10636 3/20 0.48
HPGD P15428 3/20 0.48
HSD17B10 Q99714 3/20 0.48
TNKS O95271 2/20 0.48
MAOB P27338 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
LMNA P02545 1/20 0.48
GLA P06280 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21801178 0.89 CYP1A1 (0.67) CYP1A1CYP1B1CYP1A2ABCB1ABCC1
SCHEMBL25510572 0.87 TNKS (0.60) CYP1A1CYP1B1CYP1A2ABCB1ABCC1
SCHEMBL21801271 0.86 ABCB1 (0.52) CYSLTR1CYP1A1CYP1B1CYP1A2ABCB1
SCHEMBL30744107 0.86 ABCB1 (0.52) CYSLTR1CYP1A1CYP1B1CYP1A2ABCB1
SCHEMBL21801153 0.84 ABCB1 (0.53) CYSLTR1CYP1A1CYP1B1CYP1A2ABCB1
SCHEMBL21801095 0.84 TDP1 (0.64) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL21801308 0.83 ABCB1 (0.52) CYSLTR1CYP1A1CYP1B1CYP1A2ABCB1
SCHEMBL28538523 0.81 CYSLTR1 (0.56) CYSLTR1CYP1A1CYP1B1CYP1A2ABCB1
SCHEMBL21886428 0.81 MAOB (0.51) CYSLTR1CYP1A1CYP1B1CYP1A2ABCB1
SCHEMBL21801128 0.81 CYSLTR1 (0.44) CYSLTR1CYP1A1CYP1B1CYP1A2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020053249-A1 FLAVONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-03-19 WO disclosed